Product Details

Oncept IL-2

• MA holder: Boehringer Ingelheim Vetmedica Gmbh
• VM number: EU/2/13/150/001
• Territory: Northern Ireland
• Associated documents:
  • Available from EU Union Product Database
• Date of issue: 03/05/2013
• Authorisation route: Centralised
• Active substances:
  • Feline interleukin-2 recombinant canarypox virus
• Controlled drug: No
• Target species:
  • Cats
• Distribution category: POM-V